[HTML][HTML] Classification of pulmonary neuroendocrine tumors: new insights

G Pelosi, A Sonzogni, S Harari, A Albini… - … lung cancer research, 2017 - ncbi.nlm.nih.gov
Neuroendocrine tumors of the lung (Lu-NETs) embrace a heterogeneous family of
neoplasms classified into four histological variants, namely typical carcinoid (TC), atypical …

The relationship between the use of metformin and the risk of pancreatic cancer in patients with diabetes: a systematic review and meta-analysis

J Hu, HD Fan, JP Gong, QS Mao - BMC gastroenterology, 2023 - Springer
Objective We aim to evaluate the relationship between the use of metformin and the risk of
pancreatic cancer in type 2 diabetes patients. Method We systematically searched the …

Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case–control study

T Feola, G Puliani, F Sesti, R Modica… - Journal of …, 2022 - Springer
Purpose Risk factors for sporadic GEP-NENs are still not well defined. To identify the main
clinical risk factors represents the aim of this study performed by three Italian referral centers …

Cardio-metabolic indices and metabolic syndrome as predictors of clinical severity of gastroenteropancreatic neuroendocrine tumors

L Barrea, G Muscogiuri, R Modica, B Altieri… - Frontiers in …, 2021 - frontiersin.org
Background Obesity, mainly visceral obesity, and metabolic syndrome (MetS) are major risk
factors for the development of type 2 diabetes, cardiovascular diseases, and cancer. Data …

[HTML][HTML] The PANcreatic Disease ReseArch (PANDoRA) consortium: ten years' experience of association studies to understand the genetic architecture of pancreatic …

D Campa, M Gentiluomo, A Stein, MN Aoki… - Critical Reviews in …, 2023 - Elsevier
Pancreatic cancer has an incidence that almost matches its mortality. Only a small number of
risk factors and 33 susceptibility loci have been identified. so Moreover, the relative rarity of …

Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective

G Muscogiuri, B Altieri, M Albertelli, A Dotto, R Modica… - Endocrine, 2020 - Springer
Abstract Purpose Pancreatic neuroendocrine neoplasms (PNENs) are a group of clinically
rare and heterogeneous tumors of the pancreas. Currently there are no studies investigating …

Visceral obesity and metabolic syndrome are associated with well-differentiated gastroenteropancreatic neuroendocrine tumors

AP Santos, AC Santos, C Castro, L Raposo, SS Pereira… - Cancers, 2018 - mdpi.com
The determinants for gastroenteropancreatic neuroendocrine tumors (GEP-NET) recent
burden are matters of debate. Obesity and metabolic syndrome (MetS) are well established …

Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology …

A Natalicchio, A Faggiano, MC Zatelli… - Critical Reviews in …, 2022 - Elsevier
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a heterogeneous group of
malignancies derived from neuroendocrine cells that can occur anywhere along the …

A subset of large cell neuroendocrine carcinomas in the gastroenteropancreatic tract may evolve from pre-existing well-differentiated neuroendocrine tumors

G Pelosi, F Bianchi, E Dama, J Metovic, M Barella… - Endocrine …, 2021 - Springer
In the gastro-entero-pancreatic (GEP) tract, neuroendocrine neoplasms (NENs) include well
differentiated neuroendocrine tumors (NETs) and high-grade NE carcinomas (NECs), which …

Is the real prevalence of pancreatic neuroendocrine tumors underestimated? A retrospective study on a large series of pancreatic specimens

S Partelli, F Giannone, M Schiavo Lena, F Muffatti… - …, 2019 - karger.com
Background/Aims: The annual incidence of pancreatic neuroendocrine tumors (PanNET)
has been estimated to be around 0.8/100,000 inhabitants. The aim of this study was to …